Claude C. Schulman

Claude C. Schulman's AcademicInfluence.com Rankings

Claude C. Schulman

Philosophy

#6853

World Rank

#9963

Historical Rank

Logic

#3950

World Rank

#5184

Historical Rank

philosophy Degrees

Claude C. Schulman

Biology

#9305

World Rank

#12493

Historical Rank

Endocrinology

#117

World Rank

#128

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Claude C. Schulman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Claude C. Schulman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Investigation, treatment and monitoring of late-onset hypogonadism in males (2008) (703)
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. (2009) (519)
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? (2001) (485)
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. (2005) (455)
Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. (1997) (385)
Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. (2003) (381)
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. (2006) (369)
Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. (2007) (351)
Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. (2001) (346)
Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? (2003) (330)
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. (2000) (313)
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer (2007) (293)
Investigation, treatment and monitoring of late-onset hypogonadism in males. (2009) (260)
Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. (2006) (253)
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone‐refractory prostate cancer (2008) (253)
4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate Cancer (2000) (248)
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. (2003) (225)
Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH) (1995) (220)
Extraperitoneal laparoscopic radical prostatectomy. Results after 50 cases. (2001) (210)
Endocrine aspects of male sexual dysfunctions. (2010) (208)
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. (2006) (207)
Benign prostatic hyperplasia: a progressive disease of aging men. (2003) (202)
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males (2009) (196)
Investigation, treatment and monitoring of late-onset hypogonadism in males (2005) (173)
Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. (1983) (169)
PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL. (1999) (168)
ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males (2009) (162)
Trans-obturator vaginal tape (TOT) for female stress incontinence: one year follow-up in 120 patients. (2005) (158)
Prostate specific antigen density of the transition zone for early detection of prostate cancer. (1998) (152)
Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approaches (2003) (152)
Venous leakage: surgical treatment of a curable cause of impotence. (1985) (151)
Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. (1997) (151)
Computerized analysis of smooth muscle fibers in potent and impotent patients. (1991) (147)
Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan. (2003) (146)
EAU GuidelinesInvestigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations (2005) (140)
Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. (2008) (135)
A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. (2005) (133)
Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. (2009) (130)
Investigation, treatment and monitoring of late-onset hypogonadism in males. (2005) (129)
Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. (2003) (129)
Repeat prostate biopsy: who, how and when?. a review. (2002) (129)
Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. (1997) (128)
Testosterone and prostate cancer: revisiting old paradigms. (2009) (118)
Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. (2005) (116)
Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. (1993) (112)
Testosterone Deficiency Syndrome (TDS) needs to be named appropriately--the importance of accurate terminology. (2006) (110)
The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. (2007) (107)
Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma? (1986) (99)
A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction. (2007) (98)
Extraperitoneal Laparoscopic Radical Prostatectomy (2001) (97)
Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European prostate cancer detection study (2001) (92)
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. (1996) (91)
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. (2016) (88)
Laparoscopic partial nephrectomy with "on-demand" clamping reduces warm ischemia time. (2007) (87)
Retroperitoneal laparoscopic nephrectomy and other procedures in the upper retroperitoneum using a balloon dissection technique. (1994) (87)
Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination. (1997) (87)
Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. (1993) (86)
Complications for Radical Cystectomy (2000) (85)
Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study. (2006) (84)
Male andropause: myth, reality, and treatment (2002) (84)
Multicystic dysplastic kidney: natural history from in utero diagnosis and postnatal followup. (1987) (82)
Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group. (1995) (80)
Cavernous oxygen tension and smooth muscle fibers: relation and function. (1995) (80)
The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. (2006) (80)
Can careful ultrasound examination of the urinary tract exclude vesicoureteric reflux in the neonate? (1997) (80)
Urinary incontinence in Belgium: a population-based epidemiological survey. (1997) (80)
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone. (1982) (79)
Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection? (1999) (76)
Venous impotence: pathophysiology, diagnosis and treatment. (1993) (75)
Testosterone Therapy in Men With Prostate Cancer. (2016) (73)
Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride. (2005) (71)
Endoscopic treatment of vesicoureteral reflux in children. (1987) (71)
Pharmacocavernometry-cavernography in impotence. (1986) (70)
The origin of vesico-ureteric reflux in male newborns: further evidence in favour of a transient fetal urethral obstruction. (1996) (70)
Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care. (2004) (70)
Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia. (2001) (70)
Tamsulosin: 3-Year Long-Term Efficacy and Safety in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Analysis of a European, Multinational, Multicenter, Open-Label Study (1999) (68)
A simple method for measuring separate glomerular filtration rate using a single injection of 99mTc-DTPA and the scintillation camera. (1978) (67)
Laparoscopic radical prostatectomy: the learning curve (2005) (67)
Effects of atrasentan on disease progression and biological markers in men with metastatic hormone-refractory prostate cancer: Phase 3 study. (2004) (66)
Use of statins and outcome of BCG treatment for bladder cancer. (2006) (65)
Routine voiding cystourethrography is of no value in neonates with unilateral multicystic dysplastic kidney. (2005) (64)
Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score. (2001) (64)
Role of bisphosphonates in prostate cancer. (2004) (63)
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. (2004) (61)
Insights into the pathogenesis and natural history of fetuses with renal pelvis dilatation. (2005) (61)
The ureterovesical innervation. A new concept based on a histochemical study. (1972) (61)
The single ectopic ureter. (1976) (60)
Corporeal veno-occlusive dysfunction: predominantly intracavernous muscular pathology. (1997) (58)
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. (2004) (57)
Cavernometry-cavernography: its role in organic impotence. (1984) (57)
Fracture of the penis: conservative versus surgical treatment. (1987) (56)
Pathological changes in prostate lesions after androgen manipulation. (1998) (56)
Computerized measurement of penile elastic fibres in potent and impotent men. (1994) (55)
Meta-analysis of clinical trials of atrasentan 10 mg in metastatic hormone-refractory prostate cancer (2005) (54)
Laparoscopic live donor right nephrectomy: a new technique to maximize the length of the renal vein using a modified Endo GIA stapler. (2007) (52)
Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment. (2003) (52)
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer. (2011) (50)
The ageing male (2001) (48)
Role of the bulbocavernosus muscles on the mechanism of human erection. (1990) (48)
Handling and reporting of biopsy and surgical specimens of testicular cancer. (2004) (48)
Ectopic vaginal insertion of an upper pole ureter: demonstration by special sequences of magnetic resonance imaging. (1997) (47)
Modified corporoplasty for penilecurvature: 10 years' experience (1994) (46)
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. (2004) (46)
Testosterone measurement in patients with prostate cancer. (2010) (44)
Neoadjuvant hormonal deprivation before radical prostatectomy. (1993) (43)
Neoadjuvant androgen blockade prior to prostatectomy: A retrospective study and critical review (1994) (43)
Awareness of prostate cancer among the general public: findings of an independent international survey. (2003) (43)
Intermittent Versus Continuous Androgen Deprivation Therapy in Patients with Relapsing or Locally Advanced Prostate Cancer: A Phase 3b Randomised Study (ICELAND). (2016) (42)
An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less. (2003) (42)
Prostate cancer: a serious disease suitable for prevention (2009) (42)
BPH and Sexuality (1999) (41)
Parameters of erection. (1984) (41)
Fetal uropathies: diagnostic pitfalls and management. (1985) (40)
Endoscopic injections of Teflon to treat urinary incontinence in women. (1984) (40)
Endoscopic treatment of reflux: experimental study and review of Teflon and collagen. (1993) (39)
The place of surgery for vascular impotence in the third millennium. (2003) (38)
Verrucous carcinoma of the penis: importance of human papillomavirus typing for diagnosis and therapeutic decision. (1992) (38)
Early prostate cancer: prevention, treatment modalities, and quality of life issues. (2003) (38)
Electron microscopy of the human ureteric innervation. (1974) (37)
Vascular impotence: focal or diffuse penile disease. (1992) (37)
Objective criteria in the long-term evaluation of penile venous surgery. (1994) (36)
The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel. (2006) (36)
WHAT IS THE OPTIMAL REGIMEN FOR INTRAVESICAL BCG THERAPY: ARE SIX WEEKLY INSTILLATIONS NECESSARY? (1999) (36)
Association between erectile dysfunction and coronary artery disease: a case report study. (2005) (36)
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) (2005) (35)
The aging male: a challenge for urologists (2000) (35)
Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. (1994) (35)
Second‐generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow‐up (2018) (35)
Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml. (1998) (34)
The erectile angle: objective criterion to evaluate the papaverine test in impotence. (1987) (34)
Objective measurement of the different collagen types in the corpus cavernosum of potent and impotent men: an immunohistochemical staining with computerized-image analysis (2005) (34)
Use of Biopty gun for corpus cavernosum biopsies. (1990) (34)
Long‐term therapy with the dual 5α‐reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasia (2006) (33)
Transperineal radiofrequency interstitial tumor ablation (RITA) of the prostate. (1998) (33)
Complete phalloplasty using the free radial forearm flap for correcting micropenis associated with vesical exstrophy. (2001) (32)
Improving the management of patients with prostate cancer receiving long‐term androgen deprivation therapy (2012) (31)
Vesicoureteral reflux in children: endoscopic treatment. (1990) (31)
Precursors of prostatic cancer: progression, regression and chemoprevention. (1996) (29)
Assessing the attitudes to prostate cancer treatment among European male patients (2007) (29)
Hyperthermia and thermotherapy of benign prostatic hyperplasia: a critical review. (1993) (29)
Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction. (2004) (29)
Penile extensibility: to what is it related? (1992) (29)
ORIGINAL RESEARCH—PHOSPHODIESTERASE INHIBITOR THERAPY FOR ED: Pharmacotherapy for Erectile Dysfunction (2004) (29)
Results of a European Comparative Randomized Study Comparing Oral Bropirimine versus Intravesical BCG Treatment in BCG-Naive Patients with Carcinoma in situ of the Urinary Bladder (1999) (28)
Prostate capsule: computerized morphometric analysis of its components. (1995) (28)
Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. (1995) (27)
Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer. (2005) (27)
Midline omphalovesical anomalies in children: Contribution of ultrasound imaging (1988) (27)
Long-Term Aspects of Medical Treatment of BPH (2001) (27)
Neoadjuvant hormonal treatment prior to radical prostatectomy: facts and open questions. (1997) (27)
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin (2011) (27)
Chemotherapeutic prevention studies of prostate cancer. (2004) (26)
Correlation of nocturnal penile tumescence monitoring duplex ultrasonography and infusion cavernosometry for the diagnosis of erectile dysfunction. (1996) (26)
Corporeal veno-occlusive dysfunction: a distal arterial pathology? (1998) (26)
3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction (2020) (26)
Anomalies of the Renal Pelvis and Ureter (2001) (26)
Development of the hypodysplastic kidney: contribution of antenatal US diagnosis. (1987) (25)
Clinical use of prostate-specific antigen in the staging of patients with prostatic carcinoma. (1993) (25)
Laparoscopic radical prostatectomy: a European virus with global potentials. (2002) (24)
Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review (2010) (24)
Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study (2020) (24)
Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study. (1996) (24)
Ultrastructural evidence for adrenergic and cholinergic innervation of the human ureter. (1975) (23)
Endoscopic injection of Teflon for female urinary incontinence. (1983) (22)
Differential histochemical peanut agglutinin stain in benign and malignant human prostate tumors: relationship with prostatic specific antigen immunostain and nuclear DNA content. (1996) (22)
Tolerability and safety of flutamide in monotherapy, with orchiectomy or with LHRH-a in advanced prostate cancer patients. A Belgian multicenter study of 905 patients. (1996) (22)
Deep dorsal vein arterialisation in vascular impotence. (1989) (21)
Expert opinion on 6‐monthly luteinizing hormone‐releasing hormone agonist treatment with a novel depot delivery system for prostate cancer (2007) (21)
The effect of papaverine on arterial and venous hemodynamics of erection. (1987) (21)
US demonstration of pyelitis and ureteritis in children (2006) (21)
Is there a rationale for the chronic use of phosphodiesterase‐5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia? (2009) (21)
Testosterone and prostate safety. (2009) (20)
Effect of phentolamine on venous return in human erection. (1989) (20)
Does prostaglandin E1 therapy modify the intracavernous musculature? (2000) (20)
Transurethral needle ablation of the prostate: A new treatment of benign prostatic hyperplasia using interstitial low-level radiofrequency energy (1995) (20)
Comparison of anti-desmin and anti-actin staining for the computerized analysis of cavernous smooth muscle density. (1996) (20)
Transurethral needle ablation of the prostate (TUNA): pathological, radiological and clinical study of a new office procedure for treatment of benign prostatic hyperplasia using low-level radiofrequency energy. (1994) (20)
Modified corporoplasty for penile curvature: 10 years' experience. (1994) (20)
Innervation of the Ureter: A Histochemical and Ultrastructural Study (1985) (19)
Renal duplications: the impact of perinatal ultrasound on diagnosis and management. (1991) (19)
Investigation of the venous system in impotence of vascular origin (1984) (19)
[Urinary lithiasis: epidemiology and physiopathology]. (1997) (19)
Impotence due to corporeal veno-occlusive dysfunction: long-term follow-up of venous surgery. (1992) (18)
Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study. (1978) (18)
Androgens and Benign Prostatic Hyperplasia (2006) (18)
Biological Response Modifiers for the Treatment of Superficial Bladder Tumors (2000) (18)
Multicystic dysplastic kidney: evolving concepts. In utero diagnosis and post-natal follow-up by ultrasound. (1986) (17)
Study of neuropeptide Y-containing nerve fibers in the human penis (1988) (17)
What you have always wanted to know about the impact factor and did not dare to ask. (2005) (17)
Chronic prostatitis: psychosomatic incidence. (1971) (17)
New concepts of ureterovesical innervation. (1973) (17)
Comparison of laparoscopic radical prostatectomy techniques (2002) (17)
Ureterocystostomy in renal transplantation: Comparison of endo- and extravesical anastomoses (1977) (16)
Objective quantification of cavernous endothelium in potent and impotent men. (1995) (16)
Results of a phase III randomized controlled trial of the safety and efficacy of atrasentan in men with nonmetastatic hormone-refractory prostate cancer (HRPC) (2007) (16)
Study of human penile venous system and hypothesis on its behavior during erection. (1990) (15)
Localising Prostate Cancer: Comparison of Endorectal Magnetic Resonance (MR) Imaging and 3D-MR Spectroscopic Imaging with Transrectal Ultrasound-Guided Biopsy (2011) (15)
Intraurethral catheter in high-risk patients with urinary retention: 3 years of experience. (1994) (15)
Prevention and screening (2002) (14)
Extracorporeal shock wave lithotripsy for urinary stone disease: clinical experience with the electromagnetic lithotriptor 'Lithostar'. (1989) (14)
Neoadjuvant and adjuvant hormone therapy for prostate cancer (2000) (14)
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study (2005) (14)
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis]. (2004) (14)
Total replacement of both ureters by prostheses. (1976) (13)
Ectopic ureter emptying into the rectum: report of a case. (1972) (13)
A hypothesis for the higher incidence of vesico-ureteral reflux and primary megaureters in male babies (2005) (13)
Intra-arterial chemotherapy of infiltrative bladder carcinoma. (1985) (13)
[Relationship between erectile dysfunction and cardiovascular disease]. (2004) (12)
Belgian multicenter clinical study of alfuzosin, a selective alpha 1-blocker, in the treatment of benign prostatic hyperplasia. The Alfuzosin Belgian Group. (1994) (12)
Erectile dysfunction and cardiovascular diseases. (2010) (12)
Can survival be prolonged for patients with hormone-resistant prostate cancer? (2001) (12)
Opacification of the glans penis during cavernosography. (1988) (12)
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma. (1976) (12)
The need to embrace molecular profiling of tumor cells in prostate and bladder cancer. (2003) (12)
Health-related quality of life instruments in studies of adult men with testosterone deficiency syndrome: a critical assessment. (2008) (12)
Biochemical alterations of the tunica albuginea in impotence. (1997) (11)
Vesicoureteric Reflux in Children (2006) (11)
Systemic complication of intracavernous papaverine injection in patients with venous leakage. (1988) (11)
Re: Xanthogranulomatous Pyelonephritis in Childhood, by Anthony D. Abbate and Jordan Meyers, J. Urol., 116: 231-233, 1976 (1977) (11)
Conservative management of ureteric stones. (1997) (11)
Transition zone volume on transrectal ultrasonography is more accurate and reproducible than the total prostate volume (1997) (11)
Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy. (2016) (11)
Congenital uro-nephropathies: is routine voiding cystourethrography always warranted? (1998) (11)
Early adjuvant Adriamycin in superficial bladder carcinoma (2004) (10)
A shared care approach to the management of erectile dysfunction in the community (2002) (10)
56 Transobturator vaginal tape (TOT) for the treatment of female stress incontinence: One year follow-up in 100 patients (2005) (10)
Ureteric polyp as a cause of hydronephrosis in childhood. (1978) (10)
Neoadjuvant hormonal deprivation before radical prostatectomy. (1993) (10)
Clinical Outcomes and Testosterone Levels Following Continuous Androgen Deprivation in Patients with Relapsing or Locally Advanced Prostate Cancer: A Post Hoc Analysis of the ICELAND Study (2017) (10)
COMPLICATIONS OF ANDROGEN‐DEPRIVATION THERAPY IN PROSTATE CANCER: THE OTHER SIDE OF THE COIN (2009) (10)
Synergy Between Dendritic Cells and GM–CSF-secreting Tumor Cells for the Treatment of a Murine Renal Cell Carcinoma (2009) (10)
A critical analysis of Permixon™ in the treatment of lower urinary tract symptoms due to benign prostatic enlargement (2006) (10)
Handling and pathology reporting of circumcision and penectomy specimens. (2004) (9)
The First 30 Years of EUROPEAN UROLOGY (1975-2005). (2005) (9)
Percutaneous embolic occlusion of an acquired bleeding intrarenal aneurysm. (1978) (9)
The effect of obesity on disability vs mortality in older american: the potential implication of testosterone. (2007) (9)
The ureterovesical junction in children: sonographic findings after surgical or endoscopic treatment. (1992) (9)
Long-term evaluation of Transurethral Needle Ablation of the prostate (TUNA) for treatment of benign prostatic hyperplasia (BPH): clinical outcome after 5 years (2002) (9)
BASELINE DATA FROM THE COMBINATION OF AVODART™ AND TAMSULOSIN (COMBAT) TRIAL: RELATIONSHIPS BETWEEN BODY MASS INDEX (BMI) AND LUTS/BPH MEASURES (2006) (9)
[Varicocele in the adolescent]. (1985) (9)
(TURF) transurethral radiofrequency heating for benign prostatic hyperplasia at various temperatures with Thermex II: clinical experience. (1993) (8)
Fosfomycin Trometamol versus Amoxycillin Single-Dose Therapy (1988) (8)
Penile deep dorsal vein cushions and erection. (1987) (8)
Shock wave monotherapy of staghorn calculi. (1990) (8)
[A new method of cancer treatment: the use of radiofrequencies in urological tumors]. (1996) (8)
Mxt mammary-tumor treatment with a high-temperature radiofrequency ablation device. (1995) (8)
Transurethral hyperthermia for benign prostatic hypertrophy (1991) (8)
Preoperative embolization of renal tumors--comparison of different methods. (1980) (8)
Angiography in Male Impotence (1981) (8)
Evolution of cellular and humoral response against Tuberculin and antigen 85 complex during intravesical treatment with BCG of superficial bladder cancer. (1994) (7)
Is there a link between erectile dysfunction and coronary artery disease (2004) (7)
Embolization and subsequent nephrectomy in metastatic renal cell carcinoma (2004) (7)
Testosterone Deficiency: A Common, Unrecognised Syndrome? (2009) (7)
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice? (2009) (7)
Intravesical Chemotherapy for Superficial Bladder Tumors (1982) (7)
Etiology and Diagnosis of Prostate Cancer: What’s New? (1998) (6)
Endoscopic treatment of vesicoureteral reflux. (1992) (6)
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis (2003) (6)
Development of the innervation of the ureter. (1975) (6)
[Intra-cavernous collagen analysis in impotence]. (1996) (6)
The additional predictive value contributed by quantitative chromatin pattern description as compared to DNA ploidy level measurement in 257 superficial bladder transitional cell carcinomas. (1996) (6)
Blind-ending bifid and double ureters. (1983) (6)
Prevention of prostate cancer. (2000) (6)
BPH: a progressive disease of the ageing male (2002) (6)
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists (2020) (6)
Shockwave treatment of ureteric stones in situ with second-generation lithotriptor. (1990) (6)
Transrectal Ultrasound in the Diagnosis and Staging of Prostatic Carcinoma (1989) (5)
Efficacy of zoledronic acid in the treatment of bone metastases secondary to renal cell carcinoma (2004) (5)
Novel anti‐biofilm mechanism for wireless capsule endoscopy in the urinary tract: preliminary study in a sheep model (2013) (5)
Traumatic rupture of the testicle. An underestimated pathology. (1974) (5)
[Angiographic exploration of male impotence (author's transl)]. (1979) (5)
Impotence: Evaluation with Cavernosography (1987) (5)
[Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer]. (1995) (5)
Does any correlation exist between the Gleason classification system and the computer-assisted microscope analysis of Feulgen-stained nuclei features in human prostate adenocarcinoma? (1996) (5)
Vesicoureteral reflux in the dog. A histologic and radiologic evaluation. (1974) (5)
Computed tomography of the kidney. (1977) (5)
Abdominal aortic aneurysms and ureteric obstruction. (1979) (5)
The Autonomic Innervation of the Ureter and Ureterovesical Junction (1973) (5)
Female pseudohermaphroditism with supplementary phallic urethra. (1979) (5)
Management of ureteric obstruction in the solitary kidney by a segmental suspended ureteric prosthesis. (1976) (4)
[Hemodynamic role of the tunica albuginea in erection]. (1986) (4)
Difference in glycohistochemical lectin staining of collagen fibers in the corpora cavernosa of normal and impotent men. (1996) (4)
Alternating Cystoscopy with Bladder EpiCheck® in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison Model (2021) (4)
Renal allograft rejection presenting with gross hematuria: case report. (1972) (4)
[Benign hypertrophy of the prostate: which treatment, for whom?]. (1999) (4)
[Endoscopic treatment of vesico-ureteral reflux using a sub-mucous injection of Teflon paste in children. Apropos of 337 patients (491 ureters)]. (1989) (4)
Bilateral ureteric obstruction secondary to reticulum cell sarcoma. (1978) (4)
Permixon ® [lipido sterolic extract of serenoa repens (LSESr)] inhibits b-FGF- and EGF-induced proliferation of human prostate organotypic cell lines (1995) (4)
[Medical treatment of prostatic adenoma]. (1979) (4)
[Transcatheter embolization in renal pathology (author's transl)]. (1977) (4)
Neonatal congenital megaureters: trends in diagnosis and management (1992) (4)
Abstracts: Poster session (1992) (4)
Penile ossification in man. (1985) (4)
Precursors of prostatic adenocarcinoma: recent findings and new concepts. (1996) (3)
European urology: quality, impact, online. (2013) (3)
Pelvioureteric junction obstruction of the lower collecting system in incomplete ureteric duplication. (1982) (3)
Transitional cell papillary carcinoma of the bladder in a child (2006) (3)
Angiographic features of xanthogranulomatous pyelonephritis. (1979) (3)
Intravesical Cis-Platinum in Bladder Tumours: Toxicity Study (1980) (3)
Results of an European randomized study comparing radical prostatectomy and radocial prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3NoMo prostatic carcinoma (1998) (3)
Quality of life after radical prostatectomy: How to preserve potency? (2005) (3)
[Relationship between intrapenile O2 lever and quantity of intracavernous smooth muscle fibers: current physiopathological concept]. (1995) (3)
The computer-assisted microscope analysis of Feulgen-stained nuclei linked to a supervised learning algorithm as an aid to prognosis assessment in invasive transitional bladder cell carcinomas. (1996) (3)
In-vitro characterization of dihydrotestosterone-induced, epidermal growth factor-induced and basic fibroblastic growth factor-induced modifications in the growth dynamics of the human prostate-cancer cell-line lncap, du145 and pc3. (1995) (3)
The detection and follow-up of fetal diseases: contributions of ultrasound. (1989) (3)
Blind ureterocele. (1986) (3)
Tamsulosin 0.4 MG once daily: 2-year follow-up efficacy & safety in 516 symptomatic BPH patients (1997) (3)
Neoadjuvant hormonal treatment of locally advanced prostate cancer: does it make sense? (1993) (3)
[The urology department]. (2002) (3)
[Congenital penile curvature (author's transl)]. (1982) (3)
Role of α1-Adrenoceptors in the Future Treatment of Urological Diseases (1999) (2)
A functional p53 protein is present in the majority of high grade transitional cell carcinoma of the bladder (1997) (2)
[Carcinoma of urinary derivation. A case and review of the literature]. (1997) (2)
The economics of treatment of benign prostatic hyperplasia (1996) (2)
Vascular impotence (2004) (2)
Development of the adrenergic innervation in the ureter and vas deferens in rabbits (1974) (2)
Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. (2008) (2)
[Endoscopic treatment of vesico-ureteral reflux in children]. (1986) (2)
Key take home messages (2006) (2)
[A new concept of ureterovesical innervation]. (1972) (2)
Staging of prostate cancer with complex PSA and complex PSA indices, free PSA ratio, PSAD and PSA-TZ: Results of the prospective european prostate cancer detection and staging study (2003) (2)
Strategies for the Chemoprevention of Prostate Cancer: Symposium, Brussels, October 1998 (1999) (2)
Fundamental Concepts Regarding Testosterone Deficiency and Treatment (2016) (2)
[Cancer of the prostate: advances in the use of PSA and its derived indices--new tumor markers]. (1999) (2)
Separate renal function in children with vesicoureteric reflux. (1981) (2)
Sonographic evaluation of renal inflammatory diseases in children (1988) (2)
Turner phenotype with pelvic kidney and other unusual abnormalities. (1970) (2)
LHRH agonists in prostate cancer optimising testosterone control with Eligard (2005) (2)
[Prostatic cysts]. (1970) (2)
Erratum: Pharmacotherapy for erectile dysfunction (Journal of Sexual Medicine (2004) vol. 1 (128) 10.1111/j.1743-6109.2004.04021.x) (2005) (2)
214: Incidence and Risk Factors of Symptomatic DVT in Prostate Cancer Patients Undergoing Laparoscopic Radical Prostatectomy (2006) (2)
Complex PSA and complex PSA indices in combination with artificial neural networks to predict the outcome of repeat prostate biopsies: results of the European prostate cancer detection study (2002) (2)
Discussion of R. A. Janknegt's presentation (1992) (2)
Neoadjuvant combined androgen deprivation therapy in locally confined prostate carcinoma: short term results of a European randomized study (1997) (2)
Workshop summary: hormonal suppression in the neoadjuvant setting and advanced disease. (1993) (2)
A randomised clinical study of bacampicillin and amoxycillin in urinary tract infections (2005) (2)
Treatment of urinary tract infections with temocillin (1983) (2)
Prognostic value of stem cell line identification for renal cell carcinomas. (1998) (2)
Doxycycline treatment in gonorrhea. (1974) (2)
What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006 (2007) (2)
Granuloma of the distal extremity of the ureter in kidney transplantation. (1983) (2)
Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense? (1996) (2)
Small round cell sarcoma of the renal pelvis: a case report. (1972) (2)
INJECTION ENDOSCOPIQUE DE TEFLON DANS LE TRAITEMENT DE L'INCONTINENCE URINAIRE FEMININE D'EFFORT (1983) (2)
444: Effect of Dutasteride on the Incidence of Prostate Cancer (PCA) in Men with Benign Prostatic Hyperplasia (2004) (1)
647 WHAT IS THE LONG TERM PROGNOSTIC VALUE OF PROAPOPTOTIC, ANTI-APOPTOTIC, PROLIFERATION AND INVASIVENESS MOLECULAR MARKERS IN PATIENTS TREATED WITH BCG FOR HIGH RISK NON-INVASIVE BLADDER CANCER? (2009) (1)
WHAT ARE THE IMMUNOLOGICALLY ACTIVE COMPONENTS OF BCG IN BCG THERAPY OF SUPERFICIAL BLADDER CANCER (1999) (1)
[Endoscopic injection of teflon in the treatment of urinary stress incontinence in women]. (1983) (1)
Borderline surgery of invasive kidney tumours (1984) (1)
The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment. (2016) (1)
Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out (2006) (1)
[Value of renal uptake of mercury bichloride in urologic pathology]. (1970) (1)
Celebrating the 50th Volume of European Urology, “Your” Platinum Journal (2006) (1)
Phytotherapy in chronic prostatitis (2009) (1)
To the German Society of Urology – centennial celebration (2006) (1)
Controversies in Urology (CURy): What Is It All About? (2009) (1)
[Ultrastructure of the ureter]. (1973) (1)
Radical prostatectomy: consideration of the risk factors. (1997) (1)
Turapy--transurethral ablation prostatectomy by high temperature radiofrequency--preliminary results of a multicenter study. (1995) (1)
[Decrease ApoB/ApoA-1 ratio and cardiovascular risk improvement: a tadalafil pleiotropic effect? Preliminary study on healthy volunteers]. (2008) (1)
Clinical evaluation of cefoperazone in the treatment of urinary tract infection in urological practice (1982) (1)
Atrasentan: The First Endothelin Receptor Antagonist for Hormone-Refractory Prostate Cancer (2003) (1)
Prospective multicenter european study of complex PSA, CPSAD-TZ, CPSA-TZ, C/total PSA ratio, C/free PSA ratio, F/T PSA, PSAD and PSA-TZ for early prostate cancer detection in men with PSA levels B (2002) (1)
Prevention of Prostate Cancer (2000) (1)
TNM Staging System and Bladder Carcinoma: the Problems of the N Categorisation (1988) (1)
699 PATHOLOGICAL AND BIOCHEMICAL FEATURES OF CANCERS DETECTED ON SATURATION BIOPSIES IN MEN WITH PSA LEVELS 2.5 - 10NG/ML AND NEGATIVE INITIAL BIOPSIES: A MULTIINSTITUTIONAL EUROPEAN STUDY (2007) (1)
Laparoscopic radical prostatectomy Analysis of the first series of extraperitoneal approach (2001) (1)
[Laparoscopy: new technique in urology]. (1994) (1)
Hormone Therapy for Prostate Cancer: Less Is More? Introduction and Conclusions (2008) (1)
Long-term follow-up of pge, intracavernous rnjection in impotence: An histomorphometric study (1997) (1)
[Prostate-specific antigen: an evaluation 15 years after its discovery]. (1994) (1)
[Pyelic osseous formation]. (1971) (1)
[Percutaneous puncture of renal cysts]. (1972) (1)
A new modality of treatment of localized prostate cancer: Initial experience with radio frequency interstitial tumor ablation (RITA) through a transperineal ultrasound-guided approach (1997) (1)
Early adjuvant adriamycin in superficial transitional cell carcinoma of the bladder: A preliminary report (1982) (1)
The management of abdominal wall stomata: skin protection, peristomal wound healing and support for the collecting bag. A multi-center study. (1977) (1)
[Medical treatment of ureteral calculi]. (1997) (1)
Multidisciplinary Management of the Prostate Cancer Patient: Introduction and Conclusions (2008) (1)
Ethics (2000) (1)
Re: Zhihua Lu, Guiting Lin, Amanda Reed-Maldonado, Chunxi Wang, Yung-Chin Lee, Tom F. Lue. Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis. Eur Urol 2017;71:223-33: Low-intensity Extracorporeal Shock Wave Treatment of Erectile Dysfu (2017) (1)
[Erectile dysfunction: the role of Rigiscan in the diagnosis]. (1996) (1)
[A new approach in techniques to treat urinary incontinence: TVT (tension free vaginal tape)]. (2001) (1)
[Ectopic implantations of the ureter]. (1972) (1)
Neoadjuvant hormonal deprivation before radical prostatectomy. (1993) (1)
[Bladder regeneration: a case of total bladder necrosis followed by spontaneous regeneration]. (1970) (1)
[Radiologic and hemodynamic studies of sexual impotence of vascular origin]. (1984) (1)
Oxolinic acid in urinary tract infections (1980) (1)
[Peptide innervation of the penis]. (1990) (1)
Extraperitoneal Laparoscopic Radical Prostatectomy: The Brussels Technique (2005) (1)
Controversial aspects of neoadjuvant hormonal deprivation prior to radical prostatectomy (1996) (1)
Transrectal Ultrasound Prostatic Biopsy in the PSA Era: Introduction (2002) (1)
Functional evaluation at one year after extraperitoneal laparoscopic radical prostatectomy (2002) (1)
Bilateral ureterocele with calculosis. Boot shaped dilatation of the juxtavesical ureter (1977) (1)
PD-01.02 (2006) (1)
Caverno-venous leakage: retrograde opacification and resection of the deep dorsal vein completed by ligation of the crural edges of the corpora. (1987) (1)
[Value of PSA in the staging of prostatic cancer]. (1992) (1)
Introduction and Conclusions (2007) (1)
[Transrectal prostatic biopsy: the role of preventive measures]. (1997) (1)
[Reliability of endorectal echography of the prostate in the screening and staging of prostatic cancer]. (1989) (1)
[Bilateral xantogranulomatous pyelonephritis (author's transl)]. (1976) (1)
[Rupture of the testicle]. (1972) (1)
Collaborative Review – Prostate Cancer Testosterone and Prostate Cancer : Revisiting Old Paradigms (2009) (1)
[S. Raz' method of bladder suspension and treatment of cystocele in urinary stress incontinence (short-term results)]. (1992) (1)
Clinical outcomes and testosterone levels following continuous androgen deprivation (CAD) in patients with relapsing or locally advanced prostate cancer (PC): A post hoc analysis of the ICELAND study (2016) (1)
[Intravenous urography in the management of prostatic adenoma]. (1987) (0)
La prévention du cancer de la prostate est-elle possible? (2001) (0)
Renal pseudotumors (2004) (0)
[Study of doxycycline in urinary infections]. (1969) (0)
[Complications of ureteroscopy]. (1997) (0)
[Phallography: new method of penile plethysmography for the diagnosis of impotence]. (1981) (0)
[Partial androgenic deficit in the aging male]. (2002) (0)
A simple maneuver to replace dislodged laparoscopic port. (2004) (0)
Re: Statins, Especially Atorvastatin, May Favorably Influence Clinical Presentation and Biochemical Progression-free Survival after Brachytherapy for Clinically Localized Prostate Cancer (2006) (0)
804Laparoscopic partial nephrectomy with extra-corporeal clamping: A new technique to reduce warm ischemia time (2005) (0)
Editorial (2001) (0)
[Congenital curvatures of the penis]. (1988) (0)
[The role of echography in nephritic colic]. (1987) (0)
Treating the Patient or Prostate?: Satellite Symposium held at the 13th Congress of the European Association of Urology, Barcelona, March 1998: Proceedings (1998) (0)
[Endoscopic treatment of vesico-ureteral reflux in children]. (1986) (0)
The use of the scintillation camera in the study of vesico-ureteral reflux. (1972) (0)
[Physiopathology of the vesico-ureteral reflux]. (1979) (0)
487Laparoscopic approach of gentao urinary prolapse (2005) (0)
[Bladder puncture in children]. (1976) (0)
[Phallography : a new technique for the detection of impotence (author's transl)]. (1981) (0)
Corporeal venous insufficiency results from endothelial cells alterations of the helecine arteries (1997) (0)
POD-08.02: Prostate biopsy indications: practice patterns and the potential role of PCA3 (2007) (0)
"Litotomía; ovvero del cavar la pietra" por Tommaso Alghisi (1669-1713). (2000) (0)
[Emergencies in pediatric urology]. (1978) (0)
[Chemoprophylaxis of superficial bladder tumors. Results of the EORTC study]. (1986) (0)
[Gallium scintigraphy in the diagnosis of renal abscess and pyelonephritis]. (1982) (0)
Management of intractable bleeding in advanced bladder tumors. (1984) (0)
Subject Index Vol. 38, 2000 (2000) (0)
Endoscopic Injections of Teflon to Treat Urinary Incontinence in Women (1984) (0)
[Cancers of the kidney manifested by their metastases. Therapeutic approach]. (1981) (0)
Prevention of prostate cancer: The role of diet and nutrition (2002) (0)
[Kidney malformations in Turner's syndrome (author's transl)]. (1980) (0)
Early adjuvant adriamycin in superficial bladder carcinoma (1983) (0)
MP73-20 INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION IN PATIENTS WITH RELAPSING OR LOCALLY ADVANCED PROSTATE CANCER: A PHASE 3B RANDOMIZED STUDY (ICELAND) (2015) (0)
[Infection and urinary surgery]. (1970) (0)
[The current role of surgery in the treatment of urinary lithiasis]. (1988) (0)
[Round-table: Remote results of high urinary diversions in the child]. (1979) (0)
Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (2008) (0)
Abstracts Second European Symposium on Stone Disease, March 22–24, 1990, Basel, Switzerland (2004) (0)
Intravesical chemotherapy in the management of superficial bladder tumors. (1984) (0)
Introduction (1998) (0)
The Oncoforum Urology Programme: Highlights from 2007 (2008) (0)
DOES SCREENING FOR BLADDER CANCER PRODUCE A STAGE MIGRATION TOWARDS NON-MUSCLE INVASIVE CANCERS? (2009) (0)
1475: Pathological and Biochemical Features of Cancers Detected in Men with PSA Levels 1.5-4 NG/ML: A Multiinsitutional European Pooled Analysis (2006) (0)
The Oncoforum Urology Programme (2007) (0)
Erratum (2008) (0)
[The status of medical imagery in pediatric urology]. (1987) (0)
[Study of a new nitrofurantoin with prolonged action. "Furophen T-caps" in urinary infections]. (1977) (0)
Endoscopic management of rare congenital malformations of the male urethra. (1977) (0)
Prenatal Diagnosis of Foetal Urological Abnormalities by Ultrasonography (1981) (0)
[Echographic diagnosis of fetal urinary malformations (author's transl)]. (1981) (0)
Telerobotic laparoscopic extraperitoneal radical prostatectomy with the Da Vinci-system : advantages and present limitations (2002) (0)
UIJ - Magnetic resonance guided focused ultrasound surgery (MRgFUS) for prostate cancer (2008) (0)
MP25-09 SECOND GENERATION OF TEMPORARY IMPLANTABLE NITINOL DEVICE (ITIND) IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS): WHO PROFIT MOST FROM TREATMENT? 2YEAR RESULTS OF THE MT-02-STUDY (2020) (0)
Blind duplication of the ureter (1984) (0)
Genitourinary System: An introduction (2007) (0)
Chemotherapeutic prevention studies of prostate cancer. Discussion (2004) (0)
[Severe chemical cystitis due to a combination of iodine contrast medium and chlorhexidine]. (1973) (0)
[Fetal uropathies. Diagnostic and therapeutic problems]. (1985) (0)
Peut-on prevenir le cancer de la prostate: Rôle de la nutrition (2003) (0)
[Surgery of the cavernous body in the correction of congenital curvature of the penis without hypospadias]. (1982) (0)
Magnetic Resonance Guided Focused Ultrasound Surgery (MRgFUS) for Prostate Cancer (2008) (0)
We visited for you: the Urological Clinic of the University of Padua. (1975) (0)
567Zoledronic acid provides long-term reduction of bone pain in patients with bone metastases secondary to prostate cancer (2005) (0)
[Endoscopic injection of Teflon in the treatment of urinary stress incontinence in women]. (1983) (0)
[Erectile dysfunction and phosphodiesterase type 5 inhibitors]. (2003) (0)
Peroperative Contact Radiography in Kidney Stone Surgery (1981) (0)
Dysfonctionnement érectile: la place du Rigiscan dans le diagnostic. (1996) (0)
[Limitations and feasibility of tomodensitometry of the kidney]. (1977) (0)
[Calculi: interventional treatment]. (1997) (0)
The relationship of blood urea nitrogen and serum uric acid: a computerized analysis. (1972) (0)
[Simplified prostatic biopsy by transrectal route]. (1970) (0)
CS4 Bone Lesions in Hormone Refractory Prostate Cancer (HRPC) (2006) (0)
620: Effective Synergy Between Dendritic Cells and GM-CSF Secreting Tumor Cell Vaccines for the Treatment of Murine Renal Cell Carcinoma (2005) (0)
Session 8 S24. Prevention of prostate cancer: The role of diet and nutrition (2002) (0)
[Treatment of inflammatory disease of the prostate with non-steroid anti-inflammatory agents]. (1983) (0)
Report on the 'International Symposium on Urolithiasis Research' Davos, March 29 to April 1, 1976. (1976) (0)
[Gallium scanning in the diagnosis and treatment of renal abscess (author's transl)]. (1982) (0)
ORAL IMMUNOTHERAPY OF RECURRENT URINARY TRACT MULTICENTER STUDY INFECTIONS : A DOUBLE-BLIND PLACEBO-CONTROLLED (2000) (0)
[Polycystic kidney disease. Oligo-anuria caused by compression of the ureter]. (1973) (0)
808 Transurethral needle ablation for chronic non bacterial prostatitis: A 3-year follow-up study (2004) (0)
Concensus meeting in new approaches in the pharmacotherapy of Benign Prostatic Hyperplasia (1996) (0)
Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localized prostate cancer (2006) (0)
[A case of sigmoido-urethral fistula]. (1969) (0)
Surgical treatment of benign prostatic hypertrophy. (1993) (0)
The 99mTc-DTPA Functional Study in the Child and the Adult (1981) (0)
CAN PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE IMPROVE PREOPERATIVE STAGING OF PROSTATE CANCER IN PATIENTS WITH SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BELOW 10 NG/ML? (1999) (0)
[Laparoscopic surgery in urology: current status and trends in 1993]. (1994) (0)
[Complications of surgery of hypospadias]. (1989) (0)
154 COULD SCREENING FOR BLADDER CANCER PRODUCE A STAGE MIGRATION TOWARDS DETECTION OF NON-MUSCLE-INVASIVE CANCERS? (2011) (0)
[Importance of selective arteriography of the internal pudendal artery in the diagnosis of sexual impotence of somatic origin]. (1981) (0)
PD-01.01 (2006) (0)
[Ectopic ureteral implantations. Conclusions]. (1973) (0)
96: Long-Term, Multicenter, Double-Blind Study of Prophylactic Treatment of Recurrent Urinary Tract Infections in Female Patients Using an Escherichia Coli Extract (OM-89) (2004) (0)
[Xanthogranulomatous pyelonephritis: angiographic aspects]. (1977) (0)
[Endoscopic teflon injection in the treatment of female stress urinary incontinence]. (1983) (0)
[Predictive value of the serum PSA level in patients having undergone neo-adjuvant hormone treatment before radical prostatectomy]. (1995) (0)
Is there still a place for open retropubic prostatectomy today for Benign Prostatic Hyperplasia (BPH) (2002) (0)
Editorial comment on four papers about testosterone deficiency presented at the 5th World Congress on the Aging Male (2006) (0)
Collaborative Review - Prostate Cancer Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks (2009) (0)
PD-02.07 (2006) (0)
Prostate Cancer Intermittent Versus Continuous Androgen Deprivation Therapy in Patients with Relapsing or Locally Advanced Prostate Cancer : A Phase 3 b Randomised Study ( ICELAND ) (2016) (0)
Treating the patient or prostate?, Barcelona, Spain, 21 March 1998: Introduction (1998) (0)
SERUM PROSTATE-SPECIFIC ANTIGEN IS A PREDICTOR OF THE TRANSITION ZONE VOLUME RATHER THAN TOTAL PROSTATE VOLUME IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (2006) (0)
[Urinary tract abnormalities in Turner's syndrome (author's transl)]. (1980) (0)
[The effects of mepartricin on the symptomatology of prostatic hypertrophy--double-blind controlled trial]. (1991) (0)
[Clinical and bacteriological testing of a combination of a new antibiotic and an azo dye in urology]. (1970) (0)
Re: xanthogranulomatous pyelonephritis in childhood. (1977) (0)
501Effective synergy between dendritic cells and GM-CSF secreting tumour cell vaccines for the treatment of a murine renal cell carcinoma (2005) (0)
[Prostate-specific antigen: the most useful marker for prostate cancer]. (1993) (0)
Subject Index Vol. 36, 1999 (1999) (0)
MP01-05 THE RESULTS OF ONE ARM MULTICENTER PROSPECTIVE STUDY ON AN INNOVATIVE MINIMALLY INVASIVE SURGICAL TECHNIQUE FOR LUTS MANAGEMENT: THE SECOND GENERATION TEMPORARY IMPLANTABLE NITINOL DEVICE (I-TIND) MEDITATE® (2019) (0)
Subject Index Vol. 36, 1999 (1999) (0)
Transrectal prostatic biopsy (1970) (0)
[Transcutaneous treatment of renal lithiasis]. (1983) (0)
Spermatic Phlebography Diagnostic and Therapeutic Method (1981) (0)
[Emergency diseases of male genital organs]. (1978) (0)
[Emergencies in pediatric urology]. (1978) (0)
[The role of neoadjuvant treatment prior to radical prostatectomy]. (1992) (0)
[Ureteral obstruction in polycystic kidney]. (1973) (0)
[Pipemidic acid in the prevention of recurring cystitis in women]. (1987) (0)
Facing and Avoiding Urological Complications of Prostate Cancer: Satellite Symposium held at the 12th Congress of the European Association of Urology, Paris, September 1996: Proceedings (1997) (0)
[Use of 5-alpha-reductase inhibitors in the prevention of prostate cancer]. (2004) (0)
[Prenatal diagnosis of fetal diseases of the lower urinary tract]. (1989) (0)
236: Transurethral Needle Ablation for Chronic Non Bacterial Prostatitis: A 3-Year Follow-Up Study (2004) (0)
1567: Statins are Potentially Harmful for Patients with Non-muscle Invasive Bladder Cancer Receiving Bacillus Calmette-Guerin (2007) (0)
[Urologic repercussions of advanced uterine prolapse]. (1970) (0)
Operation to correct penile deformity (1996) (0)
Metastatic, hormone refractory prostate cancer: a randomised phase II study of the endothelin-a receptor antagonist atrasentan (2002) (0)
[Rare malignant tumors of the kidney]. (1981) (0)
Renal tubular function in unilateral acute obstructive uropathy (1982) (0)
[Computerized axial tomography, a new method of examining renal and retroperitoneal structures]. (1976) (0)
1070 STATINS ARE POTENTIALLY HARMFUL FOR PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER RECEIVING BACILLUS CALMETTE-GUERIN (2007) (0)
[Association of a cyst and tumor in a kidney]. (1972) (0)
Contents Vol. 38, 2000 (2000) (0)
[Studies of combination trimethoprim-sulfamethoxazole in urology]. (1971) (0)
THE AGING MALE : A CHALLENGE FOR THE UROLOGIST (2003) (0)
[Solitary pelvic kidney]. (1970) (0)
[Ureter malformations and renal dysplasia--an embryological concept (author's transl)]. (1978) (0)
Modified specimen retrieval facilitates urethro‐vesical anastomosis in laparoscopic radical prostatectomy (2005) (0)
[The treatment of a staghorn calculus using extracorporeal lithotripsy as single therapy]. (1988) (0)
Analyse du collagène intracaverneux dans l'impuissance. (1996) (0)
Prevention of Prostate Cancer: The Role of Diet (2003) (0)
[Intravesical chemotherapy in superficial tumors of the bladder]. (1983) (0)
Cabanas Approach: Is It a Reliable Sentinel Node for Staging Penile Carcinoma? (1988) (0)
Techniques for performing cavernosometry and cavernosography. (1988) (0)
Radical prostatectomy with or without neoadjuvant hormonal therapy (1994) (0)
[Is it possible to prevent prostate cancer?]. (2001) (0)
[Ultrasonic nephrography]. (1970) (0)
Editorial Comment: Transurethral Needle Ablation of The Prostate (1996) (0)
[Value of combined ampicillin-kanamycin in urologic surgery]. (1970) (0)
210 DECREASE APOB/APOA-1 RATIO AND CARDIOVASCULAR RISK IMPROVEMENT: A TADALAFIL PLEIOTROPIC EFFECT? (2009) (0)
[Electrostimulation in the treatment of urinary incontinence in women. Preliminary study]. (1987) (0)
617 Atrasentan delays disease progression in men presenting with metastatic hormone refractory prostate cancer (2004) (0)
[Association of renal and ureteral malformations: an embryogenic hypothesis]. (1976) (0)
[Prenatal diagnosis of urinary tract malformations: therapeutic approach]. (1985) (0)
Robot assisted cystectomy in the presence of a colostomy (2019) (0)
How Do We Deal with Rising PSA after Primary Therapy (2002) (0)
[Diagnostic approaches in calculi]. (1997) (0)
Importance of deep abdominal palpation in the perinatal diagnosis of urologic malformations. (1984) (0)
Round Table: New Frontiers in Sexual Medicine: L10: TESTOSTERONE IN PDE5-I NON RESPONDERS (2004) (0)
Treatment of cryptorchidism. (1977) (0)
[Transurethral thermotherapy by radiofrequency at various temperatures in benign prostatic hypertrophy. Clinical experience with Thermex II Direx]. (1993) (0)
[Congenital urologic diseases: the importance of diagnosis in children]. (1977) (0)
[Surgical treatment of organic impotence caused by venous drainage]. (1984) (0)
[Comparison of various technics in the diagnosis of varicocele]. (1985) (0)
LBA01-06 LONG TERM FOLLOW-UP OF AN INTERNATIONAL MULTICENTER PROSPECTIVE STUDY IN APPLICATION OF TEMPORARY IMPLANTABLE NITINOL DEVICE (iTind) IN MEN WITH LOWER URINARY TRACT SYMPTOMS FOR BPH (2022) (0)
Vesicoureteric reflux: endoscopic correction by injection of teflon and collagen, an experimental and pathological study (1989) (0)
Interview with: Claude Schulman. (2006) (0)
Hormone Therapy for Prostate Cancer: Exploring Current Controversies (2009) (0)
Increasing role of prostate specific antigen (PSA) in the clinical staging of prostate cancer patients (2007) (0)
327 Rapid recovery of continence and erection following technical improvements in laparoscopic radical prostatectomy (2004) (0)
[A metabolic approach to patients with calculi]. (1997) (0)
[Bladder rupture in children due to endoxan-induced cystitis]. (1973) (0)
[The course of renal function in vesicorenal reflux. Study using I-123 Hippuran]. (1987) (0)
CORPOREAL WNO-OCCLUSIVE DYSFUNCTION: PREDOMINANTLY INTRACAWRNOUS MUSCULAR PATHOLOGY (1997) (0)
Transurethral nedle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia (1994) (0)
841: Power Color Doppler Transrectal Ultrasound (PCD-TRUS) Can Replace Biopsy of the Anastomotic Region in Detecting Local Recurrence Following Radical Prostatectomy (2004) (0)
[Is a single prostatic biopsy sufficient for selection of medical treatment in benign prostatic hypertrophy?]. (1995) (0)
809 Long-term, multicenter, double-blind study of prophylactic treatment of recurrent urinary tract infections in female patients using an escherichia coli extract (OM-89) (2004) (0)
PSA: an update. (2006) (0)
Second generation of temporary implantable nitinol device (iTind) in men with lower urinary tract symptoms (LUTS): Who profit most from treatment? 2 year results of the MT-02-study (2020) (0)
Computed Tomography of Bladder Tumours (1980) (0)
[Transureterostomy in urological reoperations]. (1981) (0)
Multivariate analysis combining prostate specific antigen density of the total prostate and of the transition zone and free/total PSA ratio for prostate cancer prediction (1997) (0)
[Antenatal diagnosis of fetal urinary tract malformations by echography (author's transl)]. (1981) (0)
[Association of renal and ureteral malformations: an embryogenic hypothesis]. (1976) (0)
[Vesico-renal reflux (author's transl)]. (1980) (0)
[Transcutaneous nephrostomy. Peculiar indications]. (1983) (0)
Reply to Ruth E. Langley, Patricia Price and Paul D. Abel’s Letter to the Editor re: Claude C. Schulman, Jacques Irani, Juan Morote, et al. Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review. Eur Urol Suppl 2010;9:675–91 (2011) (0)
PATHOLOGICAL AND BIOCHEMICAL FEATURES OF CANCERS DETECTED IN MEN WITH PSA LEVELS 1.5-4 NG/ML: A MULTI INSITUTIONAL EUROPEAN POOLED ANALYSIS (2006) (0)
[Injuries of the kidney]. (1978) (0)
Involvement of isoprenyl pathway in b-FGF- and EGF-induced proliferation of human prostate organotypic cultures (1995) (0)
[Kidney cancer--ureteral epithelioma developing with the appearance of a retroperitoneal tumor compressing the ureter]. (1978) (0)
[Role of the prostatic capsule in the physiopathology of benign prostatic hypertrophy]. (1994) (0)
Bone alkaline phosphatase & extent of skeletal disease burden in a clinical trial of atrasentan are predictive of clinical disease progression in hormone refractory prostate cancer (2001) (0)
[Treatment of urinary lithiasis using extracorporeal shock waves. Experience with the "Lithostar" electromagnetic lithotripser]. (1988) (0)
933 MRI AND PROSTATE CANCER: THE INFLUENCE OF PROSTATE WEIGHT ON TUMOUR LOCALIZATION (2009) (0)
177 Power colour doppler transrectal ultrasound (PCD-TRUS) can replace biopsy of the anastomotic region in detecting local recurrence following radical prostatectomy (2004) (0)
[Endoscopic teflon injection in the treatment of female stress urinary incontinence]. (1984) (0)
Thermotherapy and BPH (1993) (0)
DNA histogram typing in human seminomas. (1993) (0)
European Urology Supplements: Introduction (2006) (0)
Transition zone PSA density enhances prostate cancer prediction in patients with serum prostate specific antigen (PSA) below 10 NG/ML (1997) (0)
[Simple bilateral ureteral ectopy (without duplication)]. (1973) (0)
[Isotope lymphography]. (1973) (0)
Management of Prostate Cancer: A European-American Encounter, International Symposium, Munich, November 1996 (1997) (0)
In Memory of John Fitzpatrick (2014) (0)
[Laparoscopy in urology]. (2003) (0)
Erectile Dysfunction as a Sentinel Marker fo Cardiovascular Disease (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Claude C. Schulman?

Claude C. Schulman is affiliated with the following schools:

Claude C. Schulman's Academic­Influence.com Rankings

Why Is Claude C. Schulman Influential?

Claude C. Schulman's Published Works

Published Works

What Schools Are Affiliated With Claude C. Schulman?

Claude C. Schulman's AcademicInfluence.com Rankings